Needham & Company LLC Reaffirms “Buy” Rating for RxSight (NASDAQ:RXST)
Needham & Company LLC restated their buy rating on shares of RxSight (NASDAQ:RXST – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $43.00 target price on the stock. Several other brokerages also recently commented on RXST. Jefferies Financial Group began coverage on shares of RxSight in a research note […]
